APLS
Apellis Pharmaceuticals, Inc. · Healthcare · Biotechnology
Momentum-inputs (vergelijkbare managers):
breedte van houders +18.2% ·
aandelenstroom -4.3% ·
netto nieuwe posities +15.4%
— formule
Versnippering van eigendom — meer houders, kleinere totale positie
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q4 2024
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q1 2026 | 99 | +3 | 79.10M | $3.12B | +14 | −12 |
| Q4 2025 | 97 | +1 | 73.39M | $1.84B | +2 | — |
| Q3 2025 | 19 | +1 | 50.24M | $1.14B | +1 | −1 |
| Q2 2025 | 16 | +2 | 43.69M | $756.24M | +2 | — |
| Q1 2025 | 11 | -2 | 24.93M | $545.30M | +1 | −3 |
| Q4 2024 | 13 | +2 | 23.82M | $760.24M | +3 | −1 |
| Q3 2024 | 10 | +2 | 20.37M | $587.46M | +2 | — |
| Q2 2024 | 8 | — | 21.17M | $811.69M | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Management ✦ | 11.80M | -24.2% | $376.57M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 2 | Wellington Management ✦ | 11.80M | -24.2% | $376.57M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 3 | Wellington Management ✦ | 11.80M | -24.2% | $376.57M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 4 | Wellington Management ✦ | 11.80M | -24.2% | $376.57M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 5 | Wellington Management ✦ | 11.80M | -24.2% | $376.57M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 6 | State Street Global Advisors ✦ (passief) | 4.53M | — | $144.40M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | AQR Capital Management ✦ | 1.86M | +127.2% | $59.24M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 8 | AQR Capital Management ✦ | 1.86M | +127.2% | $59.24M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 9 | AQR Capital Management ✦ | 1.86M | +127.2% | $59.24M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 10 | AQR Capital Management ✦ | 1.86M | +127.2% | $59.24M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 11 | Geode Capital Management ✦ (passief) | 1.84M | +1.6% | $58.70M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 12 | Geode Capital Management ✦ (passief) | 1.84M | +1.6% | $58.70M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 13 | Point72 Asset Management ✦ | 1.27M | Nieuw | $40.46M | 0.1% | New | 1 | SEC ↗ |
| 14 | Norges Bank ✦ (passief) | 1.09M | +1.7% | $34.66M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 15 | Millennium Management ✦ | 575.49K | +643.7% | $18.36M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 16 | T. Rowe Price ✦ | 358.58K | -5.2% | $11.44M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 17 | T. Rowe Price ✦ | 358.58K | -5.2% | $11.44M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 18 | Renaissance Technologies ✦ | 271.91K | -27.0% | $8.68M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 19 | Citadel Advisors ✦ | 112.42K | -43.3% | $3.59M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 20 | Marshall Wace ✦ | 85.50K | +292.4% | $2.73M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 21 | Marshall Wace ✦ | 85.50K | +292.4% | $2.73M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 22 | Marshall Wace ✦ | 85.50K | +292.4% | $2.73M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 23 | Gotham Asset Management ✦ | 24.30K | Nieuw | $775,381 | 0.0% | New | 1 | SEC ↗ |
| 24 | D. E. Shaw & Co. ✦ | 20.00K | Nieuw | $638,200 | 0.0% | New | 1 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Point72 Asset Management | $40.46M | 0.1% |
| Gotham Asset Management | $775,381 | 0.0% |
| D. E. Shaw & Co. | $638,200 | 0.0% |
Verlaten
| Two Sigma Investments | $1.70M | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 320 houders, 137.95M aandelen, $5.43B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.